On this page
Update: January 2022
Forms and strengths
- 250 mg tablet (ethionamide or prothionamide)
- 125 mg dispersible tablet (ethionamide), to be dispersed in 10 ml water
Dosage
- Child and adult: 15 to 20 mg/kg once daily
- Maximum dose: 1000 mg daily
|
Weight |
Daily dose |
250 mg |
125 mg dispersible tablet |
|---|---|---|---|
|
5 |
75-100 |
− |
1 tab |
|
6 |
90-120 |
− |
1 tab |
|
7 |
105-140 |
− |
1 tab |
|
8 |
120-160 |
− |
1 tab |
|
9 |
135-180 |
− |
1½ tab |
|
10 |
150-200 |
− |
1½ tab |
|
11 |
165-220 |
− |
2 tab |
|
12 |
180-240 |
− |
2 tab |
|
13 |
195-260 |
− |
2 tab |
|
14 |
210-280 |
− |
2½ tab |
|
15 |
225-300 |
− |
2½ tab |
|
16 |
240-320 |
− |
2½ tab |
|
17 |
255-340 |
− |
2½ tab |
|
18 |
270-360 |
− |
2½ tab |
|
19 |
285-380 |
− |
3 tab |
|
20 |
300-400 |
− |
3 tab |
|
21 |
315-420 |
− |
3 tab |
|
22 |
330-440 |
− |
3 tab |
|
23 |
345-460 |
− |
3 tab |
|
24 |
360-480 |
− |
3 tab |
|
25 |
375-500 |
2 tab |
− |
|
26 |
390-520 |
2 tab |
− |
|
27 |
405-540 |
2 tab |
− |
|
28 |
420-560 |
2 tab |
− |
|
29 |
435-580 |
2 tab |
− |
|
|
|||
|
30-35 |
500 |
2 tab |
− |
|
36-45 |
500 |
2 tab |
− |
|
46-55 |
750 |
3 tab |
− |
|
56-70 |
750 |
3 tab |
− |
|
> 70 |
1000 |
4 tab |
− |
Contra-indications, adverse effects, precautions
- Do not administer to patients with severe hepatic impairment.
- Administer with caution to patients with hepatic disease, diabetes or depression.
- May cause:
- frequently: gastrointestinal disturbances (abdominal or epigastric pain, diarrhoea, metallic taste, nausea and vomiting, stomatitis, etc.);
- occasionally: endocrine disorders (gynecomastia, hypothyroidism), alopecia, depression, anxiety, psychosis, seizures, peripheral neuropathy, optic neuritis, hypoglycaemia, vestibular disorders, hepatotoxicity, hypersensitivity reactions.
- For the management of adverse effects, see Appendix 17.
- Avoid or monitor combination with isoniazid or cycloserine or terizidone (increased risk of neurotoxicity) and para-aminosalicylic acid (increased risk of gastrointestinal disturbances and hypothyroidism).
- Administer concomitantly pyridoxine (vitamin B6); child: 1 to 2 mg/kg (usual range: 10 to 50 mg) once daily; adult: 100 mg once daily.
- Pregnancy: CONTRA-INDICATED
- Breastfeeding: administer pyridoxine to the mother (as above). Observe the breast-fed neonate or infant for adverse effects and supplement it with pyridoxine (1 to 2 mg/kg once daily).
Monitoring
- Symptomatic monitoring.
- Liver function and thyroid function.
Patient instructions
- Take with food and/or at bedtime to limit gastrointestinal disturbances.
- 125 mg tablets should be dispersed in 10 ml water.
- Avoid alcohol during treatment.
Remarks
- To improve tolerance, start with a low dose (e.g. 250 mg daily in adults), then increase over 1 to 2 weeks to achieve the requested dose.
- For the 6HRZEto regimen for drug-susceptible TB meningitis, the dose is 20 mg/kg once daily (max. 750 mg daily).
Storage
–
–
Below 25 °C